Suivre
Samah Tawil
Samah Tawil
Affiliation inconnue
Adresse e-mail validée de inspect-lb.org
Titre
Citée par
Citée par
Année
Pain management in hospitals: patients’ satisfaction and related barriers
S Tawil, K Iskandar, P Salameh
Pharmacy Practice (Granada) 16 (3), 2018
352018
Mandatory continuing education for pharmacists in a developing country: assessment of a three-year cycle
H Sacre, S Tawil, S Hallit, G Sili, P Salameh
Pharmacy Practice (Granada) 17 (3), 2019
292019
Attitudes of Lebanese pharmacists towards online and live continuing education sessions
H Sacre, S Tawil, S Hallit, A Hajj, G Sili, P Salameh
Pharmacy Practice (Granada) 17 (2), 2019
172019
Assessment of knowledge, attitude, and practice regarding the disposal of expired and unused medications among the Lebanese population
A Hajj, S Domiati, C Haddad, H Sacre, M Akl, M Akel, S Tawil, S Abramian, ...
Journal of Pharmaceutical Policy and Practice 15 (1), 107, 2022
92022
The Arabic urticaria activity score and chronic urticaria quality of life questionnaire: validation and correlations
S Tawil, C Irani, R Kfoury, P Salameh, I Baiardini, K Weller, M Maurer, ...
International Journal of Dermatology 59 (8), 893-901, 2020
82020
Lebanese pharmacists’ confidence and self-perceptions of computer literacy: scale validation and correlates
S Hallit, S Tawil, H Sacre, C Rahme, A Hajj, P Salameh
Journal of Pharmaceutical Policy and Practice 13, 1-8, 2020
72020
Patients’ perceptions regarding pharmacists’ healthcare services: the case of Lebanon
S Tawil, H Sacre, G Sili, P Salameh
Journal of Pharmacy Practice and Research 50 (2), 137-143, 2020
72020
Pharmacists and continuing education: a cross-sectional observational study of value and motivation
S Tawil, S Hallit, H Sacre, A Hajj, P Salameh
International Journal of Pharmacy Practice 28 (4), 380-389, 2020
62020
Enoxaparin 20 mg for thromboprophylaxis in severe renal impairment
LR Karaoui, S Tawil, P Salameh, N Chamoun
Journal of International Medical Research 47 (1), 225-234, 2019
62019
The specialized competency framework for community pharmacists (SCF-CP) in Lebanon: validation and evaluation of the revised version
F Sakr, M Akel, H Sacre, C Haddad, S Tawil, J Safwan, A Hajj, RM Zeenny, ...
Journal of Pharmaceutical Policy and Practice 16 (1), 77, 2023
52023
Association of chronic urticaria with psychological distress: a multicentre cross-sectional study
S Tawil, C Irani, R Kfoury, S Abramian, P Salameh, K Weller, M Maurer, ...
Acta Dermato-Venereologica 103, 2023
52023
Navigating the crisis: A review of COVID-19 research and the importance of academic publications-The case of a private university in Lebanon
N Khaddage-Soboh, S Tawil
Heliyon, 2023
2023
Mental health during COVID-19: an evaluation of an academic university’s contribution to existing research
S Tawil, P Salameh
2023
Mental health during COVID-19: an evaluation of an academic university’s contribution to existing research (preprint)
S Tawil, P Salameh
2023
Maladies causées par les mastocytes (MCDD): Epidémiologie clinique et prise en charge dans la région du Moyen-Orient
S Tawil
2021
Mast cell Driven Diseases (MCDD): clinical epidemiology and management aspects in a Middle Eastern country
S Al Tawil
Université Paris-Est, 2021
2021
Évaluation de l’urticaire à l’aide d’un outil de diagnostic autodéclaré (SRUD): une étude de validation multicentrique
S Al Tawil, C Irani, R Kfoury, S Abramian, P Salameh, K Weller, M Maurer, ...
Annales de Dermatologie et de Vénéréologie-FMC 1 (8), A223, 2021
2021
Les versions arabes du score d’activité de l’urticaire et le questionnaire sur la qualité de vie de l’urticaire chronique: validation et corrélation
S Al Tawil, C Irani, R Kfoury, P Salameh, I Baiardini, K Weller, M Maurer, ...
Annales de Dermatologie et de Vénéréologie-FMC 1 (8), A225-A226, 2021
2021
Assessment of urticaria using a self‐reported diagnosis tool (SRUD): a multicentre validation study.
S Tawil, C Irani, R Kfoury, S Abramian, P Salameh, K Weller, M Maurer, ...
Journal of the European Academy of Dermatology & Venereology 35 (10), 2021
2021
801: EFFICACY AND SAFETY OF ENOXAPARIN 20 MG SUBCUTANEOUSLY IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 4 AND 5 FOR DEEP VEIN THROMBOSIS PROPHYLAXIS
L Karaoui, S Tawil
Critical Care Medicine 39 (12), 225, 2011
2011
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20